What is NeoGenomics's cash ratio?

NeoGenomics (NEO) reported cash ratio of 1.7× in Q1 2026.

How has NeoGenomics's cash ratio changed year-over-year?

NeoGenomics's cash ratio increased by 39.6% year-over-year, from 1.2× to 1.7×.

What is the long-term trend for NeoGenomics's cash ratio?

Over 5 years (2020 to 2025), NeoGenomics's cash ratio has grown at a -10.4% compound annual growth rate (CAGR), from 3.1× to 1.8×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

NeoGenomics NEO Cash ratio

Cash ratio at other companies

Labcorp HoldingsLH

0.4×+0.2×

Quest DiagnosticsDGX

0.2×0.0×

Personalis, Inc.PSNL

1.9×-0.5×

Guardant HealthGH

3.8×+0.2×

Natera, Inc.NTRA

1.9×-0.7×

Tempus AI, Inc.TEM

1.7×+1.2×

Other financials

Income statement

See full

Revenue$186.7M+11.1%

Gross profit$80.9M+10.4%

Operating income-$18.2M+34.4%

Net income-$17.1M+34.0%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$146.1M-57.8%

Total debt$66.3M+5.3%

Total equity$828.8M-6.7%

Total assets$1.3B-15.9%

Cash flow

See full

Operating cash flow-$8.1M+67.9%

CapEx$5.0M+11.1%

Free cash flow-$13.1M+56.0%

Valuation

See full

Market cap$1.68B-21.0%

Enterprise value$1.6B-5.6%

P/S2.3×-0.9×

Profitability

See full

Gross margin43.2%-1.1pp

Operating margin-14.2%+1.1pp

Net margin-13.3%+2.4pp

FCF margin-4.9%—

Returns & leverage

See full

Return on equity-11.6%+6.2pp

Debt / equity0.1×0.0×

Current ratio4.4×+2.4×

Where this comes from

Calculated from NeoGenomics’s reported figures.

cash and equivalents/total current liabilities=1.7×

Based on the most recent quarter.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NeoGenomics's cash ratio?: NeoGenomics (NEO) reported cash ratio of 1.7× in Q1 2026.
How has NeoGenomics's cash ratio changed year-over-year?: NeoGenomics's cash ratio increased by 39.6% year-over-year, from 1.2× to 1.7×.
What is the long-term trend for NeoGenomics's cash ratio?: Over 5 years (2020 to 2025), NeoGenomics's cash ratio has grown at a -10.4% compound annual growth rate (CAGR), from 3.1× to 1.8×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.